Prelivia is patented and has been scientifically proven through animal and human studies.
Rehabtronics Receives $1.25 Million from Genome BC
Rehabtronics notes the funds will facilitate free 90-day quality improvement trials of Prelivia at qualified healthcare facilities in the United States.
